美国FDA 指导原则 成人幽门螺杆菌相关性十二指肠溃疡疾病的药物治疗 英文原版.pdfVIP

Guidance for Industry Helicobacter pylori-Associated Duodenal Ulcer Disease in Adults: Developing Drugs for Treatment DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 56